Single-ascending-dose pharmacokinetics and safety of the novel broad-spectrum antifungal triazole BAL4815 after intravenous infusions (50, 100, and 200 milligrams) and oral administrations (100, 200, and 400 milligrams) of its prodrug, BAL8557, in h (Q42262837)
Jump to navigation
Jump to search
scientific article published on January 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Single-ascending-dose pharmacokinetics and safety of the novel broad-spectrum antifungal triazole BAL4815 after intravenous infusions (50, 100, and 200 milligrams) and oral administrations (100, 200, and 400 milligrams) of its prodrug, BAL8557, in h |
scientific article published on January 2006 |
Statements
1 reference
Single-ascending-dose pharmacokinetics and safety of the novel broad-spectrum antifungal triazole BAL4815 after intravenous infusions (50, 100, and 200 milligrams) and oral administrations (100, 200, and 400 milligrams) of its prodrug, BAL8557, in h (English)
1 reference
Anne Schmitt-Hoffmann
1 reference
Brigitte Roos
1 reference
Markus Heep
1 reference
Michael Schleimer
1 reference
Erhard Weidekamm
1 reference
Tom Brown
1 reference
Michael Roehrle
1 reference
Christoph Beglinger
1 reference
1 reference
1 reference
Identifiers
1 reference